Abraxane Injection, Powder, Lyophilized, For Suspension
Product Images NDC 68817-134

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Abraxane (NDC 68817-134). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Abraxis Bioscience, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Slowly Inject The 20 mL Of 0.9% Sodium Chloride Injection, Usp, Over A Minimum Of 1 Minute, Using The Sterile Syringe To Direct The Solution Flow Onto The Inside Wall Of The Vial. (Abraxane 01)

FDA Label Image

Structural Formula For Paclitaxel (Abraxane 02)

FDA Label Image

Figure 1: Kaplan-meier Curve Of Overall Survival (intent-to-treat Population) (Abraxane 03)

Figure 1: Kaplan-meier Curve Of Overall Survival (intent-to-treat Population) (Abraxane 03)
This appears to be a table representing the proportion of survival over time (in months) for two different groups (Amx/cEM and GaM), with the number of participants at risk at each time point listed. The percentages in the last row may represent the overall survival rate at the end of the observation period.*
FDA Label Image

Principal Display Panel (100 mg Vial)

FDA Label Image

Principal Display Panel (100 mg Vial)

FDA Label Image

Principal Display Panel (100 mg Vial Carton)

Principal Display Panel (100 mg Vial Carton)
This is a description of a pharmaceutical product called Abraxane, which is an injectable suspension available in vials. The text lists the quantity of the medication per vial in milligrams.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.